Complete platform for cell line construction, process development and antibody quality analysis.
End-to-End Biological CDMO Services
Featured in cell culture development, OPM offers End-to-End CDMO services for therapeutic protein development and manufacturing. Our CDMO facilities are operated under cGMP guidance to serve different stages, from antibody discovery to commercial-scale manufacturing up to 2000L/batch. OPM’s meticulous service and experienced scientists have contributed to the development of 200+ biologics and supported global clients in completing IND applications at FDA and NMPA. We strive to improve the efficiency for clients.
